3Vote!
Click World News (Free subscription) | yesterday
Welcome to the sixth serialized installment of J.C. Hutchins' human cloning thriller 7th Son: Descent. If this is your first exposure to our free serialization of 7th Son, you can easily catch up by experiencing part one, part two, part three, part four and part five. You can also dive in right away, thanks to... THE STORY SO FAR: John, Kilroy2.0, Father Thomas and four other unwitting human clones...
+Vote!
New Scientist (Free subscription) | yesterday
Each weighs only 30 grams but carries motion sensors, can change course and warn fellow craft of obstacles, and could even carry a small camera
4Vote!
New Scientist (Free subscription) | 25/11/2009
The editor of New Scientist magazine was invited to speak at a reception for the UK's National Science Learning Centre – here is his speech
4Vote!
New Scientist (Free subscription) | 25/11/2009
There is much more to volcanoes than just fireballs and noxious gas – see a different side of them in our gallery
4Vote!
New Scientist (Free subscription) | 25/11/2009
A mutation found in three cases of pandemic swine flu has raised fears that the virus is becoming nastier, but the evidence doesn't show anything of the kind
4Vote!
Medical News Today (Free subscription) | 25/11/2009
Two separate studies published in the current issue of Cell Transplantation (18:8), - now freely available on-line at http://www.ingentaconnect.com/content/cog/ct - have shown that transplanted human-derived umbilical cord blood (UCB) stem cells transplanted in an animal model had positive therapeutic effects on specific lung and heart disorders the animal models.
4Vote!
Medical News Today (Free subscription) | 25/11/2009
For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought. Reporting in Oncogene, a publication of Nature Publishing Group, the research teams of Anthony Atala, M.D.
4Vote!
New Scientist (Free subscription) | 24/11/2009
Today's stories on newscientist.com, at a glance, including: a robot arm that opens doors for wheelchair users, the last bastion of Antarctic ice that now seems to be melting, and a competition to win a special edition of Origin of Species
4Vote!
Medical News Today (Free subscription) | 24/11/2009
The generation of new nerve cells in the brain is regulated by a peptide known as C3a, which directly affects the stem cells' maturation into nerve cells and is also important for the migration of new nerve cells through the brain tissue, reveals new research from the Sahlgrenska Academy published in the journal Stem Cells.
5Vote!
Serendipity (Free subscription) | 24/11/2009
Pages - 421. Published in 2004 by Simon & Schuster. Challenges - Fall Into Reading. This book had been on my TBR list for ages, after I chose it as one of my Friday Finds at the beginning of the year. I was lucky enough to find it in the library in the YA section and picked it up quick. It is quite a big and bulky book, so it did take me a little while to actually read it. The story revolves around...
7Vote!
underdogs bite upwards (Free subscription) | 22/11/2009
I didn't pounce on this story straight away because I wondered if it could be a hoax. More and more, it's looking real. Mark Wadsworth has a list of links to those covering the story in detail, which I won't because others have done it better . As Mr. W. points out, the newspapers are intent on burying the story under the guise of 'University computer hacked - all rather dull - nothing to see here'...
3Vote!
LifeNews.com (Free subscription) | 21/11/2009
Washington, DC (LifeNews.com) -- Advanced Cell Technology is at it again. The human cloning company that thrives on overstated press releases that capture the media's attention and temporarily drive up its stock prices is announcing yet another attempt at launching a trial with patients receiving injections of embryonic stem cells.
4Vote!
Medical News Today (Free subscription) | 21/11/2009
Advanced Cell Technology, Inc. (OTCBB:ACTC) announced that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases...
3Vote!
Hawaii Right to Life (Free subscription) | 21/11/2009
Controversial Human Cloning Company Applies Again for Embryonic Stem Cell Trial
4Vote!
Medical News Today (Free subscription) | 20/11/2009
A study in this week's edition of The Lancet reports that the use of human embryonic stem-cells (hESCs) is a promising alternative for producing temporary skin substitutes for patients awaiting skin grafts after, for example, serious burn injuries. The article is the work of Dr Christine Baldeschi, INSERM and Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, Evry Cedex, France,...
Videos